Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maria Cristina Cardia is active.

Publication


Featured researches published by Maria Cristina Cardia.


European Journal of Medicinal Chemistry | 2008

Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives

Franco Chimenti; Rossella Fioravanti; Adriana Bolasco; Fedele Manna; Paola Chimenti; Daniela Secci; Francesca Rossi; Paola Turini; Francesco Ortuso; Stefano Alcaro; Maria Cristina Cardia

A series of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives were synthesized and assayed as inhibitors of MAO-A and MAO-B isoforms. Most of the tested compounds showed inhibitory activity with micromolar values and MAO-A selectivity. In addition a computational work was carried out on the most selective compound 3b to highlight the most relevant interactions in the mechanism of recognition within both the MAO-A and the MAO-B enzyme active sites.


Journal of Medicinal Chemistry | 2011

3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: a new scaffold for the selective inhibition of monoamine oxidase B.

Elias Maccioni; Stefano Alcaro; Roberto Cirilli; S. Vigo; Maria Cristina Cardia; Maria Luisa Sanna; Rita Meleddu; Matilde Yáñez; Giosuè Costa; Laura Casu; Péter Mátyus; Simona Distinto

3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles were designed, synthesized, and tested as inhibitors against human monoamine oxidase (MAO) A and B isoforms. Several compounds, obtained as racemates, were identified as selective MAO-B inhibitors. The enantiomers of some derivatives were separated by enantioselective HPLC and tested. The R-enantiomers always showed the highest activity. Docking study and molecular dynamic simulations demonstrated the putative binding mode. We conclude that these 1,3,4-oxadiazoles derivatives are promising reversible and selective MAO-B inhibitors.


European Journal of Medicinal Chemistry | 2010

Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase

Elias Maccioni; Stefano Alcaro; Francisco Orallo; Maria Cristina Cardia; Simona Distinto; Giosuè Costa; Matilde Yáñez; Maria Luisa Sanna; S. Vigo; Rita Meleddu; Daniela Secci

Some differently substituted 3-aryl-4,5-dihydropyrazoles-1-carbothioamides have been synthesised with the aim to investigate their monoamine oxidase inhibitory activity. The chemical structures of the compounds have been characterized by means of their IR, (1)H NMR, (13)C NMR spectroscopic data and elemental analyses. All the active compounds showed a selective activity towards the B isoform of the enzyme, regardless of the substitution on the heterocyclic ring. The inhibition of the enzymatic activity was measured on human recombinant MAO isoforms, expressed in baculovirus infected BTI insect cells. Docking experiments were carried out with the aim to rationalize the mechanism of inhibition of the most active and selective compound.


Farmaco | 2000

Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones.

Maria Cristina Cardia; Michela Begala; Alessandro DeLogu; Elias Maccioni; Antonio Plumitallo

Arylidenimidazoles bearing a thioethereal function in the position 2 of the imidazole ring show good antimicrobial activity. We now report on the synthesis and the biological properties of some novel arylidenisothiosemicarbazones, structurally related to the arylideneiminoimidazoles of which they can be considered the linear precursors. Particular attention has been put on the influence of structural modifications on the biological activity.


RSC Advances | 2015

Nanoincorporation of curcumin in polymer-glycerosomes and evaluation of their in vitro–in vivo suitability as pulmonary delivery systems

Maria Letizia Manca; José Esteban Peris; Virginia Melis; Donatella Valenti; Maria Cristina Cardia; Donatella Lattuada; Elvira Escribano-Ferrer; Anna Maria Fadda; Maria Manconi

The aim of this work was to deliver curcumin into the lungs by incorporating it into innovative vesicles obtained using phospholipids and high concentrations of glycerol (50%, v/v), so called glycerosomes, which were then combined with two polymers: sodium hyaluronate and trimethyl chitosan to form polymer-glycerosomes. These systems were prepared without the use of organic solvents or acidic solutions and their physico-chemical properties were fully characterized. Cryogenic transmission electron microscopy and small-angle X-ray scattering showed that both glycerosomes and polymer-glycerosomes were spherical, mainly unilamellar and of nanometric size (65–112 nm). The vesicles were readily nebulized with the largest amount of curcumin being found in the latest stages of the Next Generation Impactor™. In vitro results revealed the high biocompatibility of samples especially those containing the polymers. Curcumin loaded vesicles were also able to protect in vitro A549 cells stressed with hydrogen peroxide, restoring healthy conditions, not only by directly scavenging free radicals but also by indirectly inhibiting the production of cytokine IL6 and IL8. Moreover, in vivo results in rats showed the high capacity of these formulations to favour the curcumin accumulation in the lungs confirming their potential use as a target system for the treatment of pulmonary diseases.


Farmaco | 1998

New cycloalkylpyrazoles as potential cyclooxygenase inhibitors.

Maria Cristina Cardia; Luciana Corda; Anna Maria Fadda; Anna Maria Maccioni; Elias Maccioni; Antonio Plumitallo

In this study some cycloalkyl-3-(N-substituted carbamoyl)-1-phenylpyrazoles have been synthesized in order to screen their capability to inhibit human cyclooxygenase. The synthetic pathway is based on the well known property of nitrilimines to undergo 1,3-dipolar cycloaddition reactions. The structures of all the synthesized compounds have been elucidated by means of both analytical and spectroscopic methods.


Magnetic Resonance in Chemistry | 2009

Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and density functional theory calculations. Investigation on a case of very remote Hammett correlation

Giovanni Cerioni; Elias Maccioni; Maria Cristina Cardia; S. Vigo; Francesca Mocci

Two series of 2,5‐diaryl‐1,3,4‐oxadiazolines have been studied by multinuclear magnetic resonance and density functional theory calculations. A full NMR spectroscopic characterization has been performed and excellent remote Hammett correlations (σp or


Farmaco | 2001

Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones

Maria Cristina Cardia; Michela Begala; Alessandro DeLogu; Elias Maccioni

\sigma_{\rm {p}}^{+}


International Journal of Pharmaceutics | 2015

Investigating the interactions of resveratrol with phospholipid vesicle bilayer and the skin: NMR studies and confocal imaging

Carla Caddeo; Maria Manconi; Maria Cristina Cardia; Octavio Díez-Sales; Anna Maria Fadda; Chiara Sinico

) have been found for para substitution in the two aryl rings through at least 11 bonds, notwithstanding the presence in the path of atoms that should act as insulators and a lack of correlation for some of the intermediate atoms. The computational investigation on the electronic delocalization, performed with the ACID (anisotropy of the induced current density) method, reveals indeed that electrons are delocalized in almost the entire molecule despite the presence of the insulators. Copyright


Carbohydrate Polymers | 2017

Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol

Carla Caddeo; Ramon Pons; Claudia Carbone; Xavier Fernàndez-Busquets; Maria Cristina Cardia; Anna Maria Maccioni; Anna Maria Fadda; Maria Manconi

9,10-Anthracenedione derivatives are known to exhibit a quite potent anticancer activity. It has also been reported that these compounds can be effectively employed in both antibacterial and antitrypanosomal therapy. Anthraquinones also exhibit some undesirable side effects, like cardiotoxicity. So many interactions seem to demonstrate that 9,10-anthracenediones strongly interact with a number of biological sites. In this paper we wish to report on the synthesis and the pharmaceutical activity of some newly synthesised derivatives containing the anthraquinone pharmacophore.

Collaboration


Dive into the Maria Cristina Cardia's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniela Secci

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge